Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Lack of KSR1 stops certain skin tumors in mice.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Activated ras can protect kidney cells from a certain substance that causes cell death.

TRPS1 is crucial for bone, kidney, and hair follicle development.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Mutations in β1 integrins cause embryonic death but have milder effects on skin.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

TBX3 gene affects horse coat color, with higher expression in darker areas.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Blocking mTORC1 reduces skin tumor growth in mice.

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Thymosin β4 may boost hair growth by aiding stem cell movement and blood vessel formation.